The present study demonstrates the importance of the CAD of TSPX in its tumor suppressor functions in prostate cancer and highlights the needs for further studies on TSPX-mediated gene regulation, thereby providing novel insights in diagnosis and prognosis for clinical treatment and management of this common cancer in men. Here, TSPYL2 is linked to prostate carcinoma.